Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation.

Frontiers in Pharmacology
Hongxue LiHongyu Kuang

Abstract

Hepatic gluconeogenesis plays an important role in maintaining the body's glucose metabolism homeostasis. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver diseases, when combined with type 2 diabetes mellitus (T2DM), it can cause severe glucose metabolism disorders. Studies have confirmed that chronic liver inflammatory lesions are the basis of T2DM combined with NAFLD (T2DM-NAFLD), inhibiting liver inflammation can improve glucose metabolism disorders. It is essential to explore safe and effective drugs to inhibit liver inflammation to improve the body's glucose metabolism disorders. Bicyclol is a biphenyl derivative that has anti-oxidative and anti-inflammatory properties. In the present study, the hepatoprotective effects and underlying mechanisms of bicyclol in T2DM-NAFLD were investigated, and T2DM-NAFLD with/without bicyclol treatment models were established. The results revealed that bicyclol alleviated fasting blood glucose, serum transaminase levels, insulin resistance, hepatic adipogenesis, lipid accumulation and markedly reduced T2DM-NAFLD rat histological alterations of livers. Not only that, bicyclol markedly attenuated T2DM-NAFLD induced production of inflammation factors (IL-1β ...Continue Reading

References

Jul 15, 1996·The Journal of Clinical Investigation·B R LandauS C Kalhan
Sep 10, 2003·American Journal of Physiology. Endocrinology and Metabolism·David E KelleySatish C Kalhan
Jan 8, 2008·The American Journal of Clinical Nutrition·Dario GiuglianoKatherine Esposito
Nov 11, 2008·Wiener medizinische Wochenschrift·Michael Roden
May 23, 2012·Islets·Hyuk KangMooYoung Choi
Jun 2, 2012·World Journal of Gastroenterology : WJG·Yoshihisa TakahashiToshio Fukusato
Jun 23, 2012·Digestive Diseases·Anja Feneberg, Peter Malfertheiner
May 21, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Hana Zelová, Jan Hošek
Jan 27, 2015·Atherosclerosis·Nwe Ni Than, Philip N Newsome
Jul 15, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Camila Oliveira de SouzaHelenir Medri de Souza
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Feb 9, 2016·Pharmacology·Magdalena BorowskaGrzegorz Dworacki
Mar 10, 2016·Inflammation·Razieh AdabimohazabAntonio Convit
Nov 4, 2016·Nature Reviews. Gastroenterology & Hepatology·Herbert TilgMichael Roden
Jan 25, 2018·The Journal of Biological Chemistry·Xianwei CuiChang Liu
Jun 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiu-Mi WuXin Jin
Aug 2, 2018·Physiological Reviews·Max C Petersen, Gerald I Shulman
Jan 23, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Renchao DongQiang Meng
Sep 2, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Penghua FangLe Bu
Jun 23, 2020·Metabolism: Clinical and Experimental·Bedair DewidarMichael Roden

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
Odyssey Application

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here